USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
U.S. Lipid Therapeutics Market
U.S. Lipid Therapeutics Market
RELEASE DATE
10-Nov-2005
10-Nov-2005
REGION
North America
North America
Research Code: F448-01-00-00-00
SKU: HC01460-NA-MR_05963
$2,450.00
In stock
SKU
HC01460-NA-MR_05963
Description
This research service analyzes the changing dynamics in the U.S. lipid therapeutics market from the period 2001-2011. Included are pipeline analysis, patient forecasts, and individual product revenue forecasts for the major products. Both products currently in the market, as well as those forecast to enter the market by 2011 are included, with an emphasis on branded drug products. The market is segmented by product class: statins, single pill combination products, cholesterol absorption inhibitors, fibrates, nicotinic acid derivatives, and bile acid sequestrants. Also included is a pipeline overview of products operating by new mechanisms of action. The products covered in this research service are used in the treatment of dyslipidemia.
Table of Contents
Executive Summary
- Introduction
Research Scope & Methodology
- Scope and Segmentation
- Research Methodology
Overview
- Introduction
- Lipids and Lipoproteins
- Dyslipidemia
- Risk Factors
- NCEP Guidelines
- Treatment Overview
- Diet/Functional Foods
- Adherence
- Market Engineering Measurements
Total Market Forecasts
- Revenue Forecasts
- Market Share Analysis
Patient Forecasts
- Prevalence of Elevated Total Cholesterol
- Prevalence of Low HDL-C
- Patients on Drug Therapy
General Market Trends
- Industry Challenges
- Market Drivers
- Market Restraints
Competitive Structure
- Overview
Frost & Sullivan Awards
- Market Leadership of the Year Award
- Competitive Strategy Leadership of the Year Award
- Product of the Year Award
- Product Line Strategy of the Year Award
- Technology Innovation of the Year Award
Overview
Market Forecasts
Overview
Market Forecasts
Overview
Market Forecasts
Overview
Market Forecasts
Overview
Market Forecasts
Overview
Market Forecasts
Decision Support Databases
Popular Topics
This research service analyzes the changing dynamics in the U.S. lipid therapeutics market from the period 2001-2011. Included are pipeline analysis, patient forecasts, and individual product revenue forecasts for the major products. Both products currently in the market, as well as those forecast to enter the market by 2011 are included, with an emphasis on branded drug products. The market is segmented by product class: statins, single pill combination products, cholesterol absorption inhibitors, fibrates, nicotinic acid derivatives, and bile acid sequestrants. Also included is a pipeline overview of products operating by new mechanisms of action. The products covered in this research service are used in the treatment of dyslipidemia.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | F448-01-00-00-00 |
| Is Prebook | No |